Zepp Health Corporation (ZEPP) Fair Value 2026

ZEPP · Consumer Electronics ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.2 /10

32 fundamental signals · 4 models active

Value Trap Risk

LOW (25/100)

Quick Summary — As of 2026-08-28, Zepp Health Corporation (ZEPP) trades at $5.04, versus a $11.88 median fair value across its 4 active models — 135.6% above the current price. QOC: 6.2/10. Value Trap Risk: 25/100 (LOW). 4/13 models active. Within that set, the Bayesian DCF component alone returns $13.87.

Key Facts

Ticker
ZEPP
Price
$5.04
Quality Score
6.2/10
Value Trap Risk
25/100
Models Active
4/13
Last Updated
Strength: CUCE Ensemble suggests +379.4% upside with 7% confidence
Risk: Limited model coverage (4/13) may reduce confidence

Is Zepp Health Corporation (ZEPP) Undervalued or Overvalued in 2026?

According to CirclFi’s 4-model valuation engine, Zepp Health Corporation (ZEPP) appears undervalued as of : the median of 4 independent fair value estimates is $11.88, 135.6% above the current price of $5.04. Estimates range from $2.12 to $24.16. ZEPP scores 6.2/10 on fundamental quality and 25/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. ZEPP’s +135.6% gap is wider than that market norm. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Zepp Health Corporation Stock in 2026? →

What Fair Value Does Each Model Give ZEPP?

4 Intrinsic Value Models vs. Current Price ($5.04)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $13.87 +175.2%
Ensemble · Low Conviction
 $24.16 +379.4%
Unlock the Full Matrix

Access 2 additional models including Dynamic NAV, Regime Cross-Sectional.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 4 Models →

Cancel anytime · No contracts · Instant access

What Is ZEPP's Fair Value Range?

Spread across 4 independent models · $2.12 to $24.16

CirclFi's 4 active models place Zepp Health Corporation (ZEPP) between $2.12 and $24.16 per share, a spread of 186% of the median. The median of that range — $11.88 — is the fair value CirclFi publishes for ZEPP, against a current price of $5.04.

Low · Regime CrossHigh · CUCE
$2.12median $11.88$24.16
Where the range comes from
Most bearish modelRegime Cross-Sectional$2.12
Most bullish modelCUCE$24.16
Model agreement3 bullish · 1 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for ZEPP. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on ZEPP, not a CirclFi price target. How each model works →

What Is Zepp Health Corporation (ZEPP) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Zepp Health Corporation's intrinsic value is estimated at a median fair value of $11.88. At a current market price of $5.04, 3 of 4 active valuation models identify upside potential, projecting a median implied return of +135.6%. Notably, CUCE sees the most upside at +379.4% (fair value: $24.16), while Regime Cross is the most conservative at -58.0% ($2.12). The spread between these extremes — +437.4% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About ZEPP?

4 of 13 models are currently active for ZEPP. Of these, 3 models suggest upside while 1 model suggests overvaluation. Taken together, their median fair value for ZEPP is $11.88 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $13.87 on its own, implying +175.2% upside from the current price. See which stocks rank higher →

How Does ZEPP Rank in Consumer Electronics?

Among 19 Consumer Electronics stocks, ZEPP ranks #9 by Quality of Company score. CirclFi's QOC score of 6.2/10 evaluates 32 fundamental signals. A score of 6.2 indicates above-average quality.

As a retail business, Zepp Health Corporation operates in a sector where gross margin expansion is a critical driver of valuation. Investors evaluating ZEPP should weigh these sector-specific dynamics alongside our model-derived fair values.

Is ZEPP a Value Trap?

CirclFi's Value Trap algorithm assigns ZEPP a score of 25/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

4 of 13 models are active for Zepp Health Corporation. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Zepp Health Corporation's fundamental quality profile registers 6.2/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +437.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ZEPP valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ZEPP's 4 active models, average confidence is 39%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Zepp Health Corporation Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Consumer Electronics Stocks Should You Also Analyze?

11 related Consumer Electronics stocks with 13-model coverage

MSNEmerson Radio Corp.QOC 6.3VUZIVuzix CorporationQOC 6.0KOSSKoss CorporationQOC 6.6BOXLBoxlight CorporationQOC 5.6UEICUniversal Electronics Inc.QOC 6.8GPROGoPro, Inc.QOC 5.5FEBOFenbo Holdings LimitedQOC 5.3CAPCCapstone Companies, Inc.QOC 3.9AXILAXIL Brands, Inc.QOC 7.7AAPLApple Inc.QOC 9.5SONYSony Group CorporationQOC 8.2

Read investment analysis: MSN · VUZI · KOSS · BOXL · UEIC · GPRO · FEBO · CAPC · AXIL · AAPL · SONY

Which Other Stocks Have a Similar Quality Score to ZEPP?

7 companies across all industries closest to ZEPP’s Quality of Company score of 6.2/10.

REALThe RealReal, Inc.QOC 6.2STIMNeuronetics, Inc.QOC 6.2MLSSMilestone Scientific Inc.QOC 6.2DTSTData Storage CorporationQOC 6.2TGENTecogen Inc.QOC 6.2ETSElite Express Holding Inc.QOC 6.2NVDANVIDIA CorporationQOC 10.0

Read investment analysis: REAL · STIM · MLSS · DTST · TGEN · ETS · NVDA

What Else Do Investors Ask About Zepp Health Corporation’s Valuation?

What is Zepp Health Corporation's intrinsic value in 2026?

CirclFi puts Zepp Health Corporation (ZEPP)'s intrinsic value at $11.88 — the median of 4 independent model estimates as of 2026-08-28, ranging from $2.12 to $24.16. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $13.87 on its own. The Quality of Company score is 6.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ZEPP overvalued or undervalued right now?

At $5.04, 3 of 4 active models suggest ZEPP may be undervalued, while 1 indicate potential overvaluation. The median of all 4 fair value estimates is $11.88, 135.6% above the current price of $5.04 — a consensus view that ZEPP is undervalued. The assessment depends on which methodology best fits Zepp Health Corporation's business model in Consumer Electronics.

What does a Quality of Company score of 6.2 mean for ZEPP?

Zepp Health Corporation's QOC of 6.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on ZEPP?

CirclFi analyzes ZEPP with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 4 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on ZEPP?

Of the 4 models currently active on ZEPP, CUCE is the most bullish at $24.16 per share, and Regime Cross-Sectional is the most bearish at $2.12. CirclFi's published fair value for ZEPP is the median of that range, $11.88, not either extreme. The gap between the two ends equals 186% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is ZEPP a value trap in 2026?

Zepp Health Corporation's Value Trap score is 25/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 4-model valuation engine, Zepp Health Corporation (ZEPP) has a median fair value of $11.88 — 135.6% above the current price of $5.04 — as of 2026-08-28.” Source: circlfi.com/stock/ZEPP/ · Methodology
Primary sources for this ZEPP valuation
  • Financial statements: Zepp Health Corporation 10-K and 10-Q filings on SEC EDGAR (CIK 0001720446) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for ZEPP as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 4 mathematical frameworks give you clarity on ZEPP.

Unlock All 4 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

2 models hidden for ZEPP Unlock All 4 — $39/mo